Controversies in the management of advanced laryngeal squamous cell carcinoma

Cancer

Volumn 101, Issue 2, 2004, Pages 211-219

  Weber, Randal S ^a   Forastiere, Arlene ^b   Rosenthal, David I ^a   Laccourreye, Ollivier ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ESOPHAGOSCOPY; HUMAN; LARYNGEAL BIOPSY; LARYNGECTOMY; LARYNGOSCOPY; LARYNX CARCINOMA; LASER SURGERY; LUNG CANCER; MALE; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SMOKING HABIT; SPEECH THERAPY; SPIROMETRY; SQUAMOUS CELL CARCINOMA; STROBOSCOPY; SWALLOWING; THORAX RADIOGRAPHY; TOXICITY; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNGOSCOPY; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT CARE PLANNING; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED; VOCAL CORDS;

EID: 3042782719     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20231     Document Type: Review

References (26)

1. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.
3. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
4. Hendrickson FR. Radiation therapy treatment of larynx cancer. Cancer. 1985;55:2058-2061.
5. Hermans R, Van den Bogaert W, Rijnders A, et al. Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumor parameters. Radiother Oncol. 1999;50:39-46.
6. Johnson JT, Myers EN, Hao SP, Wagner RL. Outcome of open surgical therapy for glottic carcinoma. Ann Otol Rhinol Laryngol. 1993;102:752-755.
7. Laccourreye O, Brasnu D, Bassot V, Ménard M, Khayat D, Laccourreye H. Cisplatin-fluorouracil exclusive chemotherapy for T1-3 N0 glottic squamous cell carcinoma complete clinical responders: five-years results. J Clin Oncol. 1996;14:2331-2336.
8. Laccourreye O, Hans S, Garcia D, Veivers D, Brasnu D, Laccourreye L. Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord. Ann Otol Rhinol Laryngol. 2002;111:204-209.
9. Laccourreye O, Salzer SJ, Brasnu D, Shen W, Laccourreye H, Weinstein GS. Glottic carcinoma with a fixed true vocal cord: outcomes after neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg. 1996;114:400-406.
10. Laccourreye O, Veivers D, Bassot V, Ménard M, Brasnu D, Laccourreye H. Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy alone regimen for cure. Ann Otol Rhinol Laryngol 2002;111:315-322.
11. Laccourreye O, Weinstein GS, Naudo Ph, Cauchois R, Laccourreye H, Brasnu D. Supracricoid partial laryngectomy after radiation failure. Laryngoscope. 1996;106:495-499.
12. Lima RA, Freitas EQ, Kligerman J, et al. Supracricoid laryngectomy with CHEP: functional results and outcome. Otolaryngol Head Neck Surg. 2001;124:258-260.
13. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Mancuso AA. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25:535-542.
14. Mendenhall WM, Morris CG, Stringer SP, et al. Voice rehabilitation after total laryngectomy and postoperative radiation therapy. J Clin Oncol. 2002;20:2500-2505.
15. Mendenhall WM, Parsons JT, Mancuso AA, Pameijer FJ, Stringer SP, Cassisi NJ. Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol. 1997;15:2394-2402.
16. Motta G, Esposito E, Cassiano B, Motta S. T1-T2-T3 glottic tumors: fifteen years experience with CO2 laser. Acta Otolaryngol Suppl. 1997;527:155-159.
17. Naudo P, Laccourreye O, Weinstein G, Jouffre V, Laccourreye H, Brasnu D. Complications and functional outcome after supracricoid partial laryngectomy with cricohyoido-epiglottopexy. Otolaryngol Head Neck Surg. 1998;118:124-129.
18. Pearson BW, Salassa JR. Transoral laser microresection for cancer of the larynx involving the anterior commissure. Laryngoscope. 2003;113:1104-1112.
19. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949-955.
20. Piquet JJ, Chevalier D. Subtotal laryngectomy with cricohyoido- epiglottopexy for the treatment of extended glottic carcinoma. Am J Surg. 1991;162:357-361.
21. Porter MJ, McIvor NP, Morton RP, Hindley AC. Audit in the management of T3 fixed cord laryngeal cancer. Am J Otolaryngol. 1998;19:360-364.
22. Spriano G, Pellini R, Romano G, Muscatello L, Roselli R. Supracricoid partial laryngectomy as salvage surgery after radiation failure. Head Neck. 2002;24:759-765.
23. Viani L, Steel PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer. 1991;67:577-584.
24. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003;129:44-49.
25. Weinstein GS, El-Sawy MM, Ruiz C, et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope. 2001;111:191-199.
26. Yang CY, Andersen PE, Everts EC, Cohen JI. Nodal disease in purely glottic carcinoma: is elective neck treatment worthwhile? Laryngoscope. 1998;108:1006-1008.